Search Results - "Mazahreh, Farah"

“Ain’t She a Bute?”: The Importance of Proper History Taking in a Case of Inappropriate Use of Horse NSAID in a Human by Sawalha, Khalid, James, Ryan, Mazahreh, Farah, Goraya, Harmeen, Habash, Fuad

“…A 41-year-old woman with no significant past medical history presented to the hospital with complaints of nausea, vomiting, and generalized weakness over two…”
Get full text

Weight loss (WL) as a predictive factor for immune oncology (IO) by Fugere, Brad, Chen, Jim Zhongning, Mazahreh, Farah, Fugere, Tyler, Mazahreh, Liyan, Safar, A. Mazin

“…e14528 Background: WL is an adverse prognostic factor/symptom reported in ~40% cancer (ca) patients (pts) at diagnosis agnostic to site or histologic grade…”
Get full text

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis by Mazahreh, Farah, Mazahreh, Liyan, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., Zhan, Fenghuang, van Rhee, Frits, Al Hadidi, Samer

“…•Of the patients treated with BsAbs, half developed an infection, and a quarter developed grade III/IV infections.•BCMA-targeting BsAbs are associated with a…”
Get full text

Visa Constraints and Career Choices for Oncologists by Mazahreh, Farah, Al-Hader, Ahmad A, Al Hadidi, Samer

Get more information

Abstract 1292: Does metastatectomy (M) facilitate cure (Cu) by restoring immunity:tumor remnant (TR) equilibrium (Eq) by Mazahreh, Farah, Chen, Zhongning, Safar, A Mazin

“…Abstract Metastatic cancer (C) is incurable save for solitary/oligometastatic presentations after curative M, a standard care agnostic to tumor (Tu) biology…”
Get full text

Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications by Mazahreh, Farah, Safar, Haya, Mazahreh, Liyan, Safar, A. Mazin

“…Abstract Immune Oncology (IO) is a novel component of the oncology armamentarium given its distinct mechanism of action, and by extension, unique mechanisms of…”
Get full text

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis by Mazahreh, Farah, Mazahreh, Liyan, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D, Zhan, Fenghuang, van Rhee, Frits, Al Hadidi, Samer

Get full text

Abstract 4385: Unprecedented tumor: immune interaction–clinical and drug-development implications by Mazahreh, Farah, Mazahreh, Liyan, Fugere, Brad, Safar, Ahmad Mazin

“…Abstract Background: Classic therapeutic (RX) oncology principles demand radiographic response or durable stable disease as surrogates of overall survival (OS)…”
Get full text

Abstract 1567: Honing in on the metastasis machinery by Chen, Jim Zhongning, Fugere, Tyler C., Mazahreh, Farah, Fugere, Bradley, Delgiacco, Eric, Safar, Ahmad Mazin M.

“…Abstract A prevailing 'principal' in oncology posits that metastases is the last step in a strict sequence of tumorigenic events. However, despite decades of…”
Get full text

Abstract 3856: Nodal metastasis as an immune indicator in cancer (ca) therapy by Fugere, Bradley, Chen, Jim, Fugere, Tyler C., Mazahreh, Farah, Thalambadu, Nishanth, Safar, A Mazin

“…Abstract Introduction: Nodal Metastasis as an Immune Indicator in Cancer (Ca) Therapy Staging (sg) is widely used to identify appropriate treatment options &…”
Get full text

Venous Thromboembolism While on Anticoagulation With Apixaban by Mazahreh, Farah, Habash, Fuad, López-Candales, Angel

“…Venous thromboembolism (VTE) is a common condition whose pathophysiology is explained by Virchow's triad with stasis, hypercoagulability, and endothelial…”
Get full text

Venous Thromboembolism While on Anticoagulation With Apixaban by Mazahreh, Farah, Habash, Fuad, López-Candales, Angel

“…Venous thromboembolism (VTE) is a common condition whose pathophysiology is explained by Virchow's triad with stasis, hypercoagulability, and endothelial…”
Get full text